Clinical Trial Update: Effects of Pioglitazone on Insulin Sensitivity in Healthy Overweight and Obese Males (MK-0000-170) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effect of pioglitazone on insulin sensitivity in healthy overweight and obese male participants; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Actos (Pioglitazone)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Healthy, Overweight | Phase 1 | Status: COMPLETED